Latest Industry Insights

In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.

Cancer Research Horizons and Diamond Light Source aim to strengthen their partnership, combining their expertise and resources to bring new cancer treatments to patients.

Parag Mallick, Stanford scientist and Nautilus co-founder, is looking to transform proteomics with a platform for proteome-wide analysis, advancing diagnostics and disease research.

Levi Rogers reviews organizational-level support for lab sustainability, including developing organizational sustainability commitments, employee reward programs and cross-organizational partnerships.

In this interview, Professor Ola Söderberg explores the development of MolBoolean, its innovative methodology and the advantages it offers over existing techniques.

Human-based researchers spend a significant portion of their time on administrative tasks, particularly participant recruitment and management. A startup company, Study Stream, aims to address this issue and make human-based research more efficient.

Dr. Eric Kelsic, CEO and co-founder of Dyno Therapeutics, explains how AI could reduce the cost of gene therapy delivery to $0.

We spoke to Prof. Nadia Rosenthal, to find out more about their new approach and how using genetically diverse mice that better reflect human diversity can help find better therapies for a variety of diseases.

The Discovery Spark program aims to help upcoming biotechnology and healthcare companies grow. In this article, we take a closer look at some of the innovative technologies of this year's Discovery Spark cohort.

At ELRIG Drug Discovery 2024, Technology Networks sat down with Miles Witham, professor of trials for older people at Newcastle University, to learn more about these challenges and how novel approaches can be used to improve current research.